Opposite effects of antimicrotubule agents on c-myc oncogene expression depending on the cell lines used.

Bourgarel-Rey, V; El Khyari, S; Rimet, O; Bordas, B; Guigal, N; Braguer, D; Seree, E; Barra, Y; Briand, C

Bourgarel-Rey, V; El Khyari, S; Rimet, O; Bordas, B; Guigal, N; Braguer, D; Seree, E; Barra, Y; Briand, C.

Affiliation

Bourgarel-Rey V; UPRES-A CNRS 6032 Faculté de Pharmacie, Marseille, France.

Eur J Cancer ; 36(8): 1043-9, 2000 May.

Article in En | MEDLINE | ID: mdl-10885610

Subject(s)

Adenocarcinoma/drug therapy; Colonic Neoplasms/drug therapy; Genes, myc/genetics; Microtubules/drug effects; Proto-Oncogene Proteins c-myc/metabolism; Blotting, Western; Caco-2 Cells/metabolism; Flow Cytometry; Gene Expression Regulation, Neoplastic/drug effects; HT29 Cells/metabolism; Humans; Polymerase Chain Reaction/methods; RNA, Messenger/metabolism; Reverse Transcriptase Polymerase Chain Reaction

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Adenocarcinoma / Genes, myc / Proto-Oncogene Proteins c-myc / Colonic Neoplasms / Microtubules Limits: Humans Language: En Journal: Eur J Cancer Year: 2000 Type: Article Affiliation country: France

Search on Google

XML

PubMed Links